Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India.
That's according to a report in The Economic Times on Tuesday, citing a company spokesperson.
While J&J had sought approval for conducting bridging trials in the country, the US-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement,
The company is exploring how to accelerate the availability of its vaccine in India, the newspaper added.


Trump says Iran war deal close as Strait of Hormuz tensions linger
Fire breaks out at New Zealand's Wellington airport, disrupting flights
Ukraine and Russia trade overnight drone strikes, officials say
UN says Taliban arrest 30 women for violating hijab rules in Afghanistan
Trump cancels US strikes on Iran, citing progress in talks
